Advertisement

Topics

ArcherDX, Inc. Company Profile

15:59 EST 18th December 2018 | BioPortfolio

ArcherDX, the NGS applications company, is developing and commercializing a novel approach to target enrichment chemistry. Next-generation sequencing technology based on Anchored Multiplexed PCR (AMP™) generates a highly enriched library of gene targets of interest for downstream genomic sequencing. Complemented by proprietary software and readily accessible reports, our technology enables dramatic enhancement in mutation detection speed as well as complex mutation identification and discovery. www.ArcherDX.com


News Articles [1 Associated News Articles listed on BioPortfolio]

Colorado BioScience Association to Honor Leading Companies and Life Science Pioneers at Awards Dinner

ArcherDX, miRagen, Biodesix Named Finalists for Company of the Year Award; Double Helix, Impressio and Inscripta Nominated for Rising Star Award Leaders of Colorado’s...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.

The application of next-generation sequencing (NGS) technology in clinical diagnostics should proceed with care. We have evaluated the clinical validity of two commercially available RNA fusion panels...

Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.

Intraductal carcinoma (IC) is the new World Health Organization designation for tumors previously called "low-grade cribriform cystadenocarcinoma" and "low-grade salivary duct carcinoma." The relation...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ArcherDX, Inc.

ArcherDX, the NGS applications company, is developing and commercializing a novel approach to target enrichment chemistry. Next-generation sequencing technology based on Anchored ...

PBM Capital Group, LLC

PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare investments. Led by Paul Manning, a successful entrepreneur, the PBM Capital Group partners...

More Information about "ArcherDX, Inc." on BioPortfolio

We have published hundreds of ArcherDX, Inc. news stories on BioPortfolio along with dozens of ArcherDX, Inc. Clinical Trials and PubMed Articles about ArcherDX, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ArcherDX, Inc. Companies in our database. You can also find out about relevant ArcherDX, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record